S. 1373 · 118th Congress · Senate

Naloxone Affordability Act of 2023

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Apr 27, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Naloxone Affordability Act of 2023

This bill requires the Government Accountability Office to study health insurance coverage and out-of-pocket costs for naloxone as an over-the-counter medication.

Naloxone is a medication that temporarily reverses opioid overdoses. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved a naloxone nasal spray (sold under the brand name Narcan) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.

Action Timeline

2
  1. APR 27, 2023IntroReferral

    Introduced in Senate

  2. APR 27, 2023IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Apr 27, 2023

Active